Dermatitis herpetiformis

  • C. Gooptu
  • F. Wojnarowska


Dermatitis herpetiformis (DH) is a rare disease characterized by a chronic, papulove-sicular eruption; it is intensely pruritic and associated with immunoglobulin A (IgA) deposition in the papillary dermis. It is accompanied by an underlying gluten-sensitive enteropathy.


Dühring’s disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  1. Dietrich W, Laag E, Bruckner-Tuderman L et al Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 1999; 113 (1): 133–6.CrossRefGoogle Scholar
  2. Fry L. Dermatitis herpetiformis. In: Wojnarowska F, Briggaman R, eds. Management of Blistering Disease. London: Chapman & Hall Medical, 1990: 139–62.Google Scholar
  3. Hardman CM, Garioch JJ, Leonard JN et al Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997; 337 (26): 1884–7.PubMedCrossRefGoogle Scholar
  4. Lewis H, Reunala T, Garioch J etal. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135: 363–7.PubMedCrossRefGoogle Scholar
  5. McFadden J, Leonard J, Powles A et al Sulphamethoxypyridazine for dermatitis, herpetiformis, linear IgA disease and cicatrical pemphigoid. Br J Dermatol 1989; 121: 759–62.PubMedCrossRefGoogle Scholar
  6. Rhodes L, Tingle M, Park B etal. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol 1959; 132: 25 7–62.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • C. Gooptu
  • F. Wojnarowska

There are no affiliations available

Personalised recommendations